Cranial Technologies Launches NMPA-Cleared Infant Head Reshaping Treatment in China at CIIE
On November 7, 2025, Cranial Technologies, a leading U.S. medical device company specializing in infant head shape conditions, officially introduced its flagship DOC Band® treatment to the Chinese market during the China International Import Expo (CIIE) held from November 5 to 10 in Shanghai.
The company has treated over 400,000 infants in the United States and Europe. Their participation in CIIE marks a significant milestone in global expansion and is their first official entry into China.
"We are truly honored to participate in CIIE for the first time — it is one of the world’s most influential platforms for global trade and innovation," said Debbie James, Chief Executive Officer of Cranial Technologies.
"CIIE provides an opportunity to establish meaningful partnerships that can help bring world-class infant care solutions to more Chinese families. Our mission aligns closely with the objectives of Healthy China 2030, making this an ideal time to begin a deeper dialogue with this important market."
Cranial Technologies enters the Chinese market amid growing awareness of plagiocephaly, commonly known as flat head syndrome, affecting newborns. Research shows about 25% of infants may need clinical treatment, a rate similar to that in international markets.
Author’s summary: Cranial Technologies expands into China with its DOC Band® treatment, aligning with Healthy China 2030 goals and addressing the rising need for plagiocephaly care among Chinese infants.